CV Sciences, Inc. Announces Expansion with the Launch of CV™ Acute and New Immunity Product Line
29 juil. 2020 08h00 HE | CV Sciences, Inc.
SAN DIEGO, July 29, 2020 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent leader in hemp derived cannabidiol (CBD) products, today...